Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chison Medical Technologies CoSHSE:688358 -1.05%93 Debt-to-EBITDA is 0.05 as of Jun. 2026, which is 67% above its 10-year median of 0.03. GuruFocus rates SHSE:688358 with a GF Score™ of 93/100 and a GF Value™ of ¥33.91 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 471 Medical Devices & Instruments companies, Chison Medical Technologies Co ranks better than 94.9% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Chison Medical Technologies Co's Debt-to-EBITDA or its related term are showing as below:
SHSE:688358'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01 Med: 0.03 Max: 0.07
Current: 0.05
During the past 10 years, the highest Debt-to-EBITDA Ratio of Chison Medical Technologies Co was 0.07. The lowest was 0.01. And the median was 0.03.
SHSE:688358's Debt-to-EBITDA is ranked better than 94.9% of 471
companies
in the Medical Devices & Instruments industry
Industry Median: 1.63
vs SHSE:688358: 0.05
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Chison Medical Technologies Co Debt-to-EBITDA Related Terms
Chison Medical Technologies Co Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chison Medical Technologies Co Debt-to-EBITDA Chart
SHSE:688358 vs ABT, SYK, MDT: Debt-to-EBITDA Comparison
For the Medical Devices subindustry, Chison Medical Technologies Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chison Medical Technologies Co Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Chison Medical Technologies Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Chison Medical Technologies Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Chison Medical Technologies Co (SHSE:688358) has a Debt-to-EBITDA of 0.05 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Chison Medical Technologies Co. This is 67% above median its historical median of 0.03. Over the past decade, Chison Medical Technologies Co's Debt-to-EBITDA has ranged from 0.01 to 0.07. According to the industry distribution chart, Chison Medical Technologies Co ranks #24 out of 471 companies in the Medical Devices & Instruments industry, placing it in the top 5.1%.
Is Chison Medical Technologies Co's Debt-to-EBITDA too high?
Chison Medical Technologies Co's current Debt-to-EBITDA of 0.05 is 67% above median its 10-year median of 0.03. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.07. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.63. Chison Medical Technologies Co's value of 0.05 is 96.9% below this industry median. Based on the distribution chart, Chison Medical Technologies Co ranks #24 out of 471 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Chison Medical Technologies Co has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chison Medical Technologies Co's Debt-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Chison Medical Technologies Co ranks #24 out of 471 companies for Debt-to-EBITDA. This places Chison Medical Technologies Co in the top 5% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 1.63. Chison Medical Technologies Co's value of 0.05 is 96.9% below this benchmark. Historically, Chison Medical Technologies Co's own Debt-to-EBITDA has ranged from 0.01 to 0.07 over the past decade. While the company's 10-year median is 0.03 vs. the industry median of 1.63, Chison Medical Technologies Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.63, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chison Medical Technologies Co's current Debt-to-EBITDA of 0.05 is 96.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Chison Medical Technologies Co. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chison Medical Technologies Co's current Debt-to-EBITDA is 0.05, which is 67% above median its own 10-year median of 0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chison Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Chison Medical Technologies Co (SHSE:688358) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥33.91, compared to a current price of ¥27.34 — trading 19.4% below its estimated fair value. The current Debt-to-EBITDA is 0.05, which is 67% above median its 10-year median of 0.03 and 96.9% below the Medical Devices & Instruments industry median of 1.63. Chison Medical Technologies Co's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Chison Medical Technologies Co (SHSE:688358), the current Debt-to-EBITDA is 0.05 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chison Medical Technologies Co (SHSE:688358) Overvalued in 2026?
Based on GuruFocus' analysis, Chison Medical Technologies Co stock appears to be undervalued.
The current stock price of ¥27.34 is trading 19.4% below its estimated GF Value™ of ¥33.91.
GuruFocus considers Chison Medical Technologies Co to be Modestly Undervalued.
Key valuation signals for SHSE:688358:
Debt-to-EBITDA: 0.05 (67% above median its 10-year median of 0.03)
GF Value™: ¥33.91 vs. price of ¥27.34 (19.4% below fair value)
Industry Position: 96.9% below the Medical Devices & Instruments median (#24 of 471)
No single metric tells the full story. See the SHSE:688358 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chison Medical Technologies Co Ltd is a manufacturer and seller of ultrasound medical imaging equipment. The company provides ultrasound diagnostic equipment, health equipment, instrumentation, electronic components, electronic products, electronic equipment, trolleys, general equipment and accessories. Its products include Color Doppler, and B/W system.
93GF Score
Get the complete analysis for SHSE:688358
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688358 has been successfully added to your 
